A somatic reference standard for cancer genome sequencing

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Craig, David W ^a   Nasser, Sara ^a   Corbett, Richard ^b   Chan, Simon K ^b   Murray, Lisa ^c   Legendre, Christophe ^a   Tembe, Waibhav ^a   Adkins, Jonathan ^a   Kim, Nancy ^c   Wong, Shukmei ^a   Baker, Angela ^a   Enriquez, Daniel ^a   Pond, Stephanie ^c   Pleasance, Erin ^b   Mungall, Andrew J ^b   Moore, Richard A ^b   McDaniel, Timothy ^c   Ma, Yussanne ^b   Jones, Steven J M ^b   Marra, Marco A ^b   Carpten, John D ^a   Liang, Winnie S ^a   more..

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c ILLUMINA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC VARIATION; GENETICS; GENOME; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; INFORMATION PROCESSING; META ANALYSIS (TOPIC); NEOPLASM; PROCEDURES; STANDARD; STANDARDS; TUMOR CELL LINE;

CELL LINE, TUMOR; DATASETS AS TOPIC; GENETIC VARIATION; GENOME; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASMS; REFERENCE STANDARDS;

EID: 84964370191     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24607     Document Type: Article

References (44)

1. Zook, J. M. et al. Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls. Nat Biotechnol. 32, 246-251 (2014).
2. Eberle, M. A. et al. Platinum Genomes: A systematic assessment of variant accuracy using a large family pedigree. Presented at the 60th Annual Meeting of The American Society of Human Genetics, October 22-26, Boston (2013)
3. Lin, M. T. et al. Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing. Am J Clin Pathol. 141, 856-866 (2014).
4. Linderman, M. D. et al. Analytical validation of whole exome and whole genome sequencing for clinical applications. BMC Med Genomics. 7, 20; doi: 10.1186/1755-8794-7-20 (2014).
5. Simen, B. B. et al. Validation of a Next-Generation-Sequencing Cancer Panel for Use in the Clinical Laboratory. Arch Pathol Lab Med. 139, 508-517 (2015).
6. Singh, R. R. et al. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J Mol Diagn. 15, 607-622 (2013).
7. Xu, H., DiCarlo, J., Satya, R. V., Peng, Q. & Wang, Y. Comparison of somatic mutation calling methods in amplicon and whole exome sequence data. BMC Genomics. 15, 244; doi: 10.1186/1471-2164-15-244 (2014).
8. Ghoneim, D. H., Myers, J. R., Tuttle, E. & Paciorkowski, A. R. Comparison of insertion/deletion calling algorithms on human nextgeneration sequencing data. BMC Res Notes. 7, 864; doi: 10.1186/1756-0500-7-864 (2014).
9. Wang, Q. et al. Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers. Genome Med. 5, 91; doi: 10.1186/gm1495 (2013).
10. Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. 463, 191-196 (2010).
11. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature. 417, 949-954 (2002).
12. Inumaru, J. S. et al. Analysis of the BRAF V600E mutation in primary cutaneous melanoma. Genet Mol Res. 13, 2840-2848 (2014).
13. Berger, M. F. et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature. 485, 502-506 (2012).
14. Egberts, F. et al. Melanomas of unknown primary frequently harbor TERT-promoter mutations. Melanoma Res. 24, 131-136 (2014).
15. Huang, F. W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science. 339, 957-959 (2013).
16. Killela, P. J. et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA 110, 6021-6026 (2013).
17. Koelsche, C. et al. Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathol. 126, 907-915 (2013).
18. Nonoguchi, N. et al. TERT promoter mutations in primary and secondary glioblastomas. Acta Neuropathol. 126, 931-937 (2013).
19. Remke, M. et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol. 126, 917-929 (2013).
20. Poulos, R. C. et al. Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome. Mol Cancer Res. 13, 1218-1226 (2015).
21. Genomic Classification of Cutaneous Melanoma. Cell. 161, 1681-1696 (2015).
22. Forbes, S. A. et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805-811 (2015).
23. Brash, D. E. UV signature mutations. Photochem Photobiol. 91, 15-26 (2015).
24. Armstrong, B. K. & Kricker, A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 63, 8-18 (2001).
25. Leiter, U. & Garbe, C. Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol. 624, 89-103 (2008).
26. Pfeifer, G. P., You, Y. H. & Besaratinia, A. Mutations induced by ultraviolet light. Mutat Res. 571, 19-31 (2005).
27. Kawanishi, S., Hiraku, Y. & Oikawa, S. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat Res. 488, 65-76 (2001).
28. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature. 500, 415-421 (2013).
29. Minoche, A. E., Dohm, J. C. & Himmelbauer, H. Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and genome analyzer systems. Genome Biol. 12, R112; doi: 110.1186/gb-2011-12-11-r112 (2011).
30. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25, 1754-1760 (2009).
31. Raczy, C. et al. Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms. Bioinformatics. 29, 2041-2043 (2013).
32. Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 28, 1811-1817 (2012).
33. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 31, 213-219 (2013).
34. Christoforides, A. et al. Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs. BMC Genomics. 14, 302; doi: 10.1186/1471-2164-14-302 (2013).
35. Ledergerber, C. & Dessimoz, C. Base-calling for next-generation sequencing platforms. Brief Bioinform. 12, 489-497 (2011).
36. Abecasis, G. R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 491, 56-65 (2012).
37. Cunningham, F. et al. Ensembl 2015. Nucleic Acids Res. 43, D662-9 (2015).
38. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
39. Liang, W. S. et al. Long insert whole genome sequencing for copy number variant and translocation detection. Nucleic Acids Res. 42, e8; doi: 10.1093/nar/gkt1865 (2014).
40. Jones, S. J. et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol. 11, R82; doi: 10.1186/gb-2010-11-8-r82 (2010).
41. Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics. 8; doi: 10.1093/bioinformatics/btv710 (2015).
42. Ivakhno, S. et al. CNAseg-a novel framework for identification of copy number changes in cancer from second-generation sequencing data. Bioinformatics. 26, 3051-3058 (2010).
43. Tan, A., Abecasis, G. R. & Kang, H. M. Unified representation of genetic variants. Bioinformatics. 31, 2202-2204 (2015).
44. Van der, Auwera. et al. In Current Protocols in Bioinformatics. Vol. 43 Ch. 11.10.1-11.10.33 (John Wiley & Sons, Inc., 2013).